K. Hilliard

Inflammatory cytokines in cystic fibrosis lungs.

M. Konstan, T. Bonfield, J. Hilliard, 1995, American journal of respiratory and critical care medicine.

Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation.

M. Konstan, M. Berger, M W Konstan, 1994, American journal of respiratory and critical care medicine.

Effect of Ibuprofen on Neutrophil Migration in Vivo in Cystic Fibrosis and Healthy Subjects

C. Hoppel, M. Konstan, P. Davis, 2003, Journal of Pharmacology and Experimental Therapeutics.

Compacted DNA nanoparticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitution.

S. L. Hyatt, Osman Muhammad, R. Stern, 2004, Human gene therapy.

A randomized double blind, placebo controlled phase 2 trial of BIIL 284 BS (an LTB4 receptor antagonist) for the treatment of lung disease in children and adults with cystic fibrosis.

L. Lands, M. Konstan, S. Heltshe, 2014, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

A phase I randomized, multicenter trial of CPX in adult subjects with mild cystic fibrosis *

N. McCarty, M. Konstan, T. Kelley, 2002, Pediatric pulmonology.

Leukotriene B4 markedly elevated in the epithelial lining fluid of patients with cystic fibrosis.

M. Konstan, J. Hilliard, R. Walenga, 1993, The American review of respiratory disease.

A phase I study assessing the safety and tolerability of allogeneic mesenchymal stem cell infusion in adults with cystic fibrosis.

A. Caplan, H. Lazarus, S. Heltshe, 2022, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Use of nasal potential difference and sweat chloride as outcome measures in multicenter clinical trials in subjects with cystic fibrosis * *

N. McCarty, M. Konstan, T. Kelley, 2002, Pediatric pulmonology.